scholarly journals Gabapentin — The Popular but Controversial Anticonvulsant Drug May Be Zeroing in on the Pathophysiology of Disease

Author(s):  
Michael Raymond Binder
Keyword(s):  
1989 ◽  
Vol 28 (03) ◽  
pp. 160-167 ◽  
Author(s):  
P. Penczek ◽  
W. Grochulski

Abstract:A multi-level scheme of syntactic reduction of the epileptiform EEG data is briefly discussed and the possibilities it opens up in describing the dynamic behaviour of a multi-channel system are indicated. A new algorithm for the inference of a Markov network from finite sets of sample symbol strings is introduced. Formulae for the time-dependent state occupation probabilities, as well as joint probability functions for pairs of channels, are given. An exemplary case of analysis in these terms, taken from an investigation of anticonvulsant drug effects on EEG seizure patterns, is presented.


Andrologia ◽  
2021 ◽  
Author(s):  
Agnieszka Matuszewska ◽  
Beata Nowak ◽  
Adam Szeląg ◽  
Anna Merwid‐Ląd ◽  
Agnieszka Partyka ◽  
...  

2021 ◽  
Vol 22 (7) ◽  
pp. 3358
Author(s):  
Anna Makuch-Kocka ◽  
Marta Andres-Mach ◽  
Mirosław Zagaja ◽  
Anna Śmiech ◽  
Magdalena Pizoń ◽  
...  

About 70 million people suffer from epilepsy—a chronic neurodegenerative disease. In most cases, the cause of the disease is unknown, but epilepsy can also develop as the result of a stroke, trauma to the brain, or the use of psychotropic substances. The treatment of epilepsy is mainly based on the administration of anticonvulsants, which the patient must most often use throughout their life. Despite significant progress in research on antiepileptic drugs, about 30% of patients still have drug-resistant epilepsy, which is insensitive to pharmacotherapy used so far. In our recent studies, we have shown that 4-alkyl-5-aryl-1,2,4-triazole-3-thiones act on the voltage-gated sodium channels and exhibit anticonvulsant activity in an MES (maximal electroshock-induced seizure) and 6Hz test in mice. Previous studies have shown their beneficial toxic and pharmacological profile, but their effect on a living organism during chronic use is still unknown. In the presented study, on the basis of the previously conducted tests and the PAMPA (parallel artificial membrane permeability assay) BBB (blood–brain barrier) test, we selected one 1,2,4-triazole-3-thione derivative—TP-315—for further studies aimed at assessing the impact of its chronic use on a living organism. After long-term administration of TP-315 to Albino Swiss mice, its effect on the functional parameters of internal organs was assessed by performing biochemical, morphological, and histopathological examinations. It was also determined whether the tested compound inhibits selected isoforms of the CYP450 enzyme system. On the basis of the conducted tests, it was found that TP-315 does not show nephrotoxic nor hepatotoxic effects and does not cause changes in hematological parameters. In vitro tests showed that TP-315 did not inhibit CYP2B6, CYP2D6, CYP3A4, or CYP3A5 enzymes at the concentration found in the serum of mice subjected to long-term exposure to this compound.


Epilepsia ◽  
1979 ◽  
Vol 20 (6) ◽  
pp. 705-710 ◽  
Author(s):  
Francesco Monaco ◽  
Roberto Mutani ◽  
Camillo Mastropaolo ◽  
Massimo Tondi

2016 ◽  
Vol 52 (23) ◽  
pp. 4389-4392 ◽  
Author(s):  
Saikat Roy ◽  
N. Rajesh Goud ◽  
Adam J. Matzger

This report highlights the discovery of new polymorph ‘form XV’, and the crystal structure of the elusive form V of the anticonvulsant drug phenobarbital.


BIOS ◽  
2010 ◽  
Vol 81 (2) ◽  
pp. 55-61
Author(s):  
Rebecca Riblet ◽  
Amanpreet Kaur ◽  
Harleen Kaur ◽  
Mark D. Womble

1990 ◽  
Vol 156 (4) ◽  
pp. 525-530 ◽  
Author(s):  
Olav M. Linaker

The frequency of psychotropic and anticonvulsant drug use in 168 institutionalised mentally retarded adults was studied. Use of neuroleptics and anticonvulsants was more frequent and use of hypnotics and antidepressants less frequent than in the general population. Neuroleptics were given to 49% of the population. Clients with no psychiatric diagnosis consumed less neuroleptics than those with such a diagnosis, and there was a non-significant trend for those with a more serious diagnosis (e.g. schizophrenia) to take a higher dosage. The degree of disruptive behaviour and the availability of a physician were related to dosage of neuroleptics. The various psychiatric diagnoses given could explain only a small proportion of the variance in dosage.


Sign in / Sign up

Export Citation Format

Share Document